.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Moodys
Merck
Daiichi Sankyo
Johnson and Johnson
McKinsey
Baxter
Harvard Business School
Cipla
Novartis

Generated: November 25, 2017

DrugPatentWatch Database Preview

MANNITOL 20% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

What is the patent landscape for Mannitol 20% In Plastic Container, and what generic Mannitol 20% In Plastic Container alternatives are available?

Mannitol 20% In Plastic Container is a drug marketed by Icu Medical Inc and B Braun and is included in two NDAs.

The generic ingredient in MANNITOL 20% IN PLASTIC CONTAINER is mannitol. There are seventeen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the mannitol profile page.

Pharmacology for MANNITOL 20% IN PLASTIC CONTAINER

Drug ClassOsmotic Diuretic
Mechanism of ActionOsmotic Activity
Physiological EffectIncreased Diuresis

Medical Subject Heading (MeSH) Categories for MANNITOL 20% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Icu Medical Inc
MANNITOL 20% IN PLASTIC CONTAINER
mannitol
INJECTABLE;INJECTION019603-004Jan 8, 1990APRXNoNo► Subscribe► Subscribe► Subscribe
B Braun
MANNITOL 20% IN PLASTIC CONTAINER
mannitol
INJECTABLE;INJECTION020006-004Jul 26, 1993APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Daiichi Sankyo
Federal Trade Commission
Baxter
Harvard Business School
Dow
QuintilesIMS
Cerilliant
Novartis
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot